Early vascular ageing (EVA), vascular risk in adolescents, neonatal factors

Excellence in standardized early vascular ageing (EVA) evaluation in large cohorts:

Since more than 20 years, VASCage researchers have gathered ample experience in developing standardized protocols for in vivo determination of EVA. Our field proven protocols were optimized and applied to ~4500 adolescents, so far: Standardization/training of procedures, Participant reported outcome measures, validated questionnaires, structured questionnaires, physical and antropometric evaluations (e.g. pulse-wave-velocity, vascular ultrasound, body composition/BIA) including pre- and postnatal information.

Large biobank of community based adolescent cohorts:

Together with the Medical University of Innsbruck, we house detailed data on vascular phenotyping, risk factors and behaviours with biosamples of 3000 adolescents with ~50% follow-up and on-going long-term follow-ups by digital health record linkage as well as pre- and postnatal information with appropriate informed consents for re-use of data. Cohort of pre-term born children with biosamples.

Excellent contact to schools and training companies:

In the federal states of Tyrol (Austria) and South-Tyrol (Italy) we have excellent contacts to schools and training-companies that were part of our adolescent health studies.

Selected Cohorts/Publications:

YOUhealTH: clinicaltrials.gov #NCT05741827, EVA4YOU: NCT04598685, EVA Tyrol: NCT03929692, NEOVASC/Neo:Core Study: NCT04413994, Kindergarden-Study (DOI: 10.1161/ATVBAHA.116.308144), ARFY-Study (DOI: 10.1161/STROKEAHA.108.525675), ARMY-Study (DOI: 10.1161/01.CIR.0000085996.95532.FF)